CVS halts federal probe with $22M settlement; Theorem Clinical Research opens facility in Germany;

> CVS ($CVS) will pay $22 million to settle a federal investigation into whether two of its Florida pharmacies were illegally selling painkillers not prescribed for legitimate uses. Story

> U.S. CRO Theorem Clinical Research is opening a clinical supplies facility in Frankfurt, Germany, in June. Report

> The U.K. is asking the industry to help it fight superbugs. Story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.